Molecular regulation of Trypanosoma congolense-induced nitric oxide production in macrophages

Rani Singh1, Bruce C Kone, Abdelilah S Gounni

  • 1Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Plos One
|March 29, 2013
PubMed

Insights

Mice resistant to Trypanosoma congolense infection show higher nitric oxide (NO) production. This resistance involves specific signaling pathways, including mitogen-activated protein kinase (MAPK) and STAT1 phosphorylation, differing between susceptible and resistant mice.

Area of Science:

  • Immunology
  • Molecular Biology
  • Parasitology

Background:

  • Trypanosoma congolense infection susceptibility varies between mouse strains (BALB/c susceptible, C57BL/6 resistant).
  • Interferon-gamma (IFN-γ) response and nitric oxide (NO) production are crucial for resistance.
  • Molecular mechanisms of NO release in macrophages upon Trypanosome infection are not fully understood.

Purpose of the Study:

  • Investigate signaling pathways in macrophages from susceptible (BALB.BM) and resistant (ANA-1) mice.
  • Determine mechanisms of Trypanosoma congolense-induced nitric oxide production.

Main Methods:

  • Used immortalized macrophage cell lines (BALB.BM, ANA-1) and primary bone marrow-derived macrophages (BMDM).
  • Stimulated cells with Trypanosoma congolense whole cell extract (TC-WCE) and IFN-γ.
  • Analyzed nitric oxide production, mitogen-activated protein kinase (MAPK) and STAT1 phosphorylation, and iNOS transcriptional promoter activation.

Main Results:

  • Resistant ANA-1 cells produced significantly higher NO levels than susceptible BALB.BM cells.
  • NO production was dependent on MAPK and STAT1 phosphorylation in both cell types.
  • Differential iNOS transcriptional promoter activation was observed, involving GAS1 and GAS2 transcription factors.

Conclusions:

  • Differential signaling pathways regulate NO production in macrophages from susceptible and resistant mice.
  • Understanding these pathways can inform immunomodulatory strategies for Trypanosome infections.